Product Category
Proteome Profiler™ 96 Phospho-RTK Array 3
Angiogenesis-related Receptor Tyrosine Kinases
The Proteome Profiler 96 Human Phospho-RTK Array 3 (Catalog # ARZ003) employs a two-site sandwich immunoassay technique to simultaneously detect 8 phosphorylated receptor tyrosine kinases (RTKs) in a single sample of cell lysate. Multiple capture antibodies that specifically recognize the target RTKs detected by the assay have been spotted into each well of a 96-well microplate.
| Antibody Well Map |
 |
| A visualization of the spot layout per well in the Proteome Profiler 96 Phospho-RTK Array 3 (Catalog # ARZ003). Each individual well is spotted with 8 different antibodies and 1 Reference Spot. The reference spot provides a strong positive signal to allow easy visualization of well location for template alignment during data analysis. |
Features
- Predefined microplate-based multiplex assay
- Simultaneously detects 8 analytes
- Utilizes small sample size (5-50 μg of cell lysate)
- 3 hour assay time
- Amenable to high-throughput
- Chemiluminescence detection
Kit Contents*
- 96-well microplate with each well spotted with 8 capture antibodies & 1 reference spot
- Anti-phospho-tyrosine-HRP Detection Antibody
- Array & Wash Buffers
- Cell Lysis Buffer
- Substrate Reagents**
- Plate Sealers
*Acquisition of data from Proteome Profiler 96 Microplate-based Antibody Arrays requires a digital imaging systems.
**Substrates 1 and 2 are comprised of TMA-6, a product of Lumigen, Inc., Southfield, Michigan, USA, and are covered by the following US Patent Numbers: 5,922,558 and 6,858,733; and International Patent Numbers: 733,086, 1,019,525, 2,300,071, 1,015,461, 2,002,352,881, ZL02805225.0, and 1,456,716
Data Example
PDGF-BB Induces RTK Phosphorylation in CCD-1070Sk Cells
 |
A. The Proteome Profiler 96 Human Phospho-RTK Antibody Array 3 (Catalog # ARZ003) was used to simultaneously assess the phosphorylation of 8 different receptor tyrosine kinases (RTKs) in lysates from the CCD-1070Sk human foreskin fibroblast cell line that was either untreated or treated with Recombinant Human PDGF-BB (Catalog # 220-BB) for 5 minutes. RS=Reference Spot. B. Histogram profiles for select RTKs were generated by quantifying the mean spot pixel densities from individual antibody spots using analytical software. |